“With testing technology rapidly evolving, the Government of Canada is moving quickly to ensure that Canadians have access to the most effective and efficient testing solutions possible. If authorized, these rapid tests will increase our capacity to detect and respond to new outbreaks, keeping Canadians healthy and safe.”
The Honourable Anita Anand
Minister of Public Services and Procurement
“As cases of COVID-19 are rising, following public health measures is important to flatten the curve. Detecting cases of COVID-19 quickly is also critical to slow the spread of the virus and today’s announcement will help increase Canada’s capacity, should the tests be authorized by Health Canada.”
The Honourable Patty Hajdu
Minister of Health
Public Services and Procurement Canada, the Public Health Agency of Canada, Health Canada and Innovation, Science and Economic Development Canada are working together to purchase and deploy COVID-19 rapid tests.
The Abbott ID NOW system is a rapid molecular point-of-care test for COVID-19. The technology can detect the virus directly from a nasal swab, returning results between 5 and 13 minutes.
The testing system is small and lightweight and can easily be transported to remote locations and operated with minimal training.
The chemicals, or reagents, used to conduct these tests do not require special storage temperatures.